Weston, FL – November 8, 2017 – BioMatrix SpRx, a growing leader in the specialty pharmacy industry, today announced the acquisition of Elwyn Pharmacy Group in Garnet Valley, Pennsylvania, 30 miles southwest of Philadelphia.
BioMatrix offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. The growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. BioMatrix excels in providing services for hemophilia and bleeding disorders, transplant therapy, IVIg and specialty care, and digital health technology.
Elwyn Pharmacy Group provides medications and supportive services for patients living with hard to treat disease states with the goal of achieving optimal patient outcomes. This is realized through compliance and individualized therapy management in an environment that maximizes patient satisfaction and adherence. Elwyn’s expertise in neurological and auto-immune disorders, fertility, oncology, and other chronic conditions has made them a leader in the specialty pharmacy industry.
As a result of this transaction, BioMatrix has expanded their services into complementary therapeutic categories requiring the same high-touch services they are accustomed to providing. BioMatrix’s national footprint increases to 11 pharmacy locations, nationwide, in key metropolitan locations. Elwyn joins the rapidly growing family of companies that comprise
BioMatrix including Matrix Health Group, Factor Support Network, Medex BioCare, and BiologicTx.
“The acquisition of Elwyn Pharmacy Group complements our strategy of bringing together leaders in the specialty pharmacy industry to provide comprehensive, compassionate care to patients living with complex, chronic diseases, “stated Bruce Greenberg, Chief Executive Officer, BioMatrix SpRx. “We are pleased to welcome Elwyn and their experienced staff to the BioMatrix family.”
“BioMatrix and Elwyn share very similar values. The success of both companies is rooted in our collaborative, compassionate patient-centered approach,” stated Nicholas Karalis, Chief Executive Officer, Elwyn Pharmacy Group. “Together, we expand our ability to provide a high level of individualized, focused care to patients living with a chronic condition. We are extremely excited to be part of this larger organization.”
About BioMatrix SpRx
BioMatrix SpRx, a portfolio company of Acon Investments and Triton Pacific Capital Partners, LLC., offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes Matrix Health Group, Factor Support Network, Medex BioCare, BiologicTx.
About Elwyn Pharmacy Group
Elwyn Pharmacy Group provides a complete range of specialty pharmacy and infusion services. We treat a wide array of complex disease states such as Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. The Elwyn Pharmacy Group includes Elwyn Pharmacy, Glen Rock Medical Pharmacy, Elwyn Specialty Care, and Med Center Specialty Pharmacy.
Being selected By Sanofi Genzyme demonstrates Elwyn Specialty Care Pharmacy’s ability to provide the highest level of service as a specialty pharmacy serving patients, prescribers, and payers in the specialty Multiple Sclerosis (MS) space
On March 2nd, 2017, Elwyn Specialty Care, a specialty pharmacy which is part of the Elwyn Pharmacy Group announced that it was been selected by Sanofi Genzyne as one of the limited group of specialty pharmacies authorized to distribute one of the manufacturer’s Multiple Sclerosis drugs—AUBAGIO® (teriflunomide). As a result of being added to this exclusive network, Elwyn Specialty Care is recognized as part of an elite limited group and is one of the only independently owned and operated specialty pharmacy’s included in the network.
AUBAGIO is a once-daily pill used to treat relapsing forms of MS that has been shown to quiet MS. AUBAGIO® (teriflunomide) is effective across key measures of disease activity: sustained disability progression (14 mg only), annualized relapse rate, and MRI activity in MS patients
“At Elwyn Specialty Care we are pleased and excited to be one of the few independent specialty pharmacies accepted into this exclusive network. Providing services to the specialty Multiple Sclerosis patients has been a passion of ours since we established our specialty pharmacy years ago. It is one of the reasons why we exist today and why we established our mission and vision as a specialty pharmacy. We feel honored to be chosen and included as part of the network”. (“Our goal is to achieve optimal patient outcomes through compliance and delivery of individualized medication therapy management in an environment that maximizes patient satisfaction and adherence”) says Nicholas Karalis, RPh, President CEO at Elwyn Pharmacy Group
About Elwyn Specialty Care Also Part of The Elwyn Pharmacy Group:
At Elwyn Specialty Care we provide medications, under a comprehensive umbrella of medication therapy management, to people living with many complex disease states. We understand the complexity of managing patients’ medication and that treatment paradigms vary greatly and are highly individualized. Our patient-centered approach enables us to adapt and customize a collaborative medication therapy management plan for every patient. It is our goal to ensure treatment success and patient safety with the highest level of focus, care and compassion possible.
Elwyn Specialty Care is part of the Elwyn Pharmacy Group and provides a complete range of specialty pharmacy and infusion services. We treat a wide array of complex disease states such as Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. Elwyn Specialty Care, a privately-held, pharmacist-owned company located in Garnet Valley, PA, is accredited by URAC, and the Accreditation Commission for Health Care (ACHC). For more information about Elwyn Specialty Care or Elwyn Pharmacy Group please contact us at 1-855-ELWYN-RX (359-9679) or visit us on the web at www.elwynspecialtycare.com or www.elwynpharmacygroup.com
Elwyn Pharmacy Group is excited to announce the addition of Marc Stranz PharmD as Vice President of Compliance. Marc has worked for more than 30 years in sterile pharmacy compounding and was an early leader in the home infusion industry. He has held branch, regional, and corporate positions with several national providers, including Senior Vice President for Clinical and Strategic Operations at Coram and Vice President of Clinical Operations and Regulatory Affairs at BioScrip. He was also Corporate Director of Infusion Services for Omnicare and Chief Clinical Officer for BioScrip Specialty Services.
A recognized business leader and subject matter expert, his work is part of the core practice standards of the industry established by professional organizations and regulatory bodies as well as the body of policy and procedure used by home infusion organizations. Dr Stranz pioneered safe and efficient provision of advanced infusion therapies in home infusion and has sustained involvement in cutting-edge therapies. His expertise includes clinical and operational services, regulatory compliance, accreditation, sterile compounding, and design/build of cleanrooms and infusion facilities. He served on the USP Expert Panel for Sterile Compounding, the Board of Pharmaceutical Specialties Practice Analysis Taskforce in Sterile Compounding, and the Institute of Environmental Sciences and Technology (IEST) Working Group for Controlled Environments per USP Chapter 797